Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Income Statement 2012–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenue | 42.2M | 26.4M | 257.2M | 211.0M | 326.6M | 475.8M | 356.1M | 0 | 1.6M | 189.5M | 30.0M | 31.1M | 2.8M | 1.9M |
| Gross Profit | 28.4M | 17.7M | 98.3M | 141.0M | 269.0M | 438.2M | 339.0M | — | — | — | — | — | — | — |
| Profitability | ||||||||||||||
| Operating Income | -181.1M | -199.7M | -203.2M | -256.9M | -263.9M | 156.3M | 107.8M | -204.4M | -232.1M | -115.9M | -219.1M | -64.7M | -36.0M | -38.5M |
| EBITDA | -179.8M | -198.1M | -200.0M | -253.3M | -260.4M | 159.2M | 111.0M | -201.2M | -228.7M | -112.9M | -217.2M | -64.0M | -35.6M | -38.3M |
| Net Income | 168.0M | 28.5M | -237.9M | -291.8M | -287.1M | 132.2M | 89.8M | -209.3M | -238.2M | -127.3M | -223.3M | -87.1M | -53.6M | -33.0M |
| Per Share Data | ||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 117M | 115M | 94M | 78M | 75M | 83M | 73M | 65M | 53M | 46M | 39M | 33M | 5M | — |
Coherus Biosciences Inc. Income Statement — FAQ
Coherus Biosciences Inc. (CHRS) income statement over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CHRS's income statement history?
The chart and table above show Coherus Biosciences Inc.'s income statement by year and by quarter, including the growth rate.